Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000001905 | SCV000915984 | pathogenic | Senior-Loken syndrome 5 | 2017-04-28 | criteria provided, single submitter | clinical testing | The IQCB1 c.424_425delTT (p.Phe142ProfsTer5) variant is a frameshift variant that is predicted to result in premature termination of the protein. The p.Phe142ProfsTer5 variant has been reported in three studies in which it is found in a total of nine individuals with Senior Loken syndrome, including in seven patients in a homozygous state and in two patients in a compound heterozygous state who both carried a null variant on the second allele (Otto et al. 2005; Estrada-Cuzcano et al. 2011; Halbritter et al. 2013). The p.Phe142ProfsTer5 variant was absent from 347 control subjects but is reported at a frequency of 0.00023 in the European (non-Finnish) population of the Exome Aggregation Consortium. Based on the evidence, the p.Phe142ProfsTer5 variant is classified as pathogenic for Senior Loken syndrome. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. |
Labcorp Genetics |
RCV000822567 | SCV000963376 | pathogenic | Nephronophthisis | 2025-01-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Phe142Profs*5) in the IQCB1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IQCB1 are known to be pathogenic (PMID: 15723066, 21901789, 23559409, 28041643). This variant is present in population databases (rs750962965, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with Leber congenital amaurosis and Senior-L√∏ken syndrome (PMID: 15723066, 20881296, 21866095, 23188109, 24625443, 28041643, 28832562). This variant is also known as c.224_225delTT, p.F142fsX146. ClinVar contains an entry for this variant (Variation ID: 1831). For these reasons, this variant has been classified as Pathogenic. |
Blueprint Genetics | RCV001073766 | SCV001239326 | pathogenic | Retinal dystrophy | 2017-12-06 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001093170 | SCV001250020 | pathogenic | not provided | 2018-05-01 | criteria provided, single submitter | clinical testing | |
Ocular Genomics Institute, |
RCV000001905 | SCV001573560 | pathogenic | Senior-Loken syndrome 5 | 2021-04-08 | criteria provided, single submitter | research | The IQCB1 c.424_425del variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PVS1, PM2, PM3. Based on this evidence we have classified this variant as Pathogenic. |
Institute of Medical Genetics and Applied Genomics, |
RCV001093170 | SCV001762005 | pathogenic | not provided | 2021-06-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001093170 | SCV001824779 | pathogenic | not provided | 2021-11-23 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 23446637, 21866095, 15723066, 28832562, 20881296, 29453417, 31980526, 32581362) |
Fulgent Genetics, |
RCV000001905 | SCV002813901 | pathogenic | Senior-Loken syndrome 5 | 2024-05-08 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000001905 | SCV004192436 | pathogenic | Senior-Loken syndrome 5 | 2024-03-25 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV001073766 | SCV005068612 | pathogenic | Retinal dystrophy | 2021-01-01 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000001905 | SCV000022063 | pathogenic | Senior-Loken syndrome 5 | 2011-02-11 | no assertion criteria provided | literature only | |
NIHR Bioresource Rare Diseases, |
RCV000505085 | SCV000598854 | pathogenic | Leber congenital amaurosis | 2015-01-01 | no assertion criteria provided | research | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000001905 | SCV000804661 | pathogenic | Senior-Loken syndrome 5 | 2016-09-01 | no assertion criteria provided | clinical testing |